Its overuse for these upregulated tumor processes and the inability of lung cancer cells to express argininosuccinate synthase (AS), the enzyme that regulates the biosynthesis of arginine, explains the decreased serum levels [53,55]. The gene discussed is ASS1; the disease is lung carcinoma.